Clinical trial
Efficacy of Neural Prolotherapy Versus Local Corticosteroid Soft Tissue Injection for Treatment of Anserine Bursitis
NCT04509440 is registered in ClinicalTrials.gov with University of Alexandria as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Neural Prolotherapy Versus Local Corticosteroid Soft Tissue Injection for Treatment of Anserine Bursitis
- Lead sponsor
- University of Alexandria
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 1, 2018
- Completion date
- October 30, 2019
- Enrollment
- 43 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anserine bursitis